PERCEPTIVE ADVISORS LLC 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 2:35 pm Sale |
2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
PERCEPTIVE ADVISORS LLC | 1,800,000 3.600% |
-350,641![]() (-16.30%) |
Filing |
2022-02-14 3:46 pm Unchanged |
2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
PERCEPTIVE ADVISORS LLC | 2,150,641 6.200% |
0 (Unchanged) |
Filing |
2021-02-16 3:30 pm Unchanged |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
PERCEPTIVE ADVISORS LLC | 2,150,641 7.000% |
0 (Unchanged) |
Filing |